The fraction of exhaled nitric oxide (FeNO) is a biomarker for type 2 inflammation in asthma, but the significance of long-term FeNO changes on relevant parameters is unclear.
No takes yet. Share an insight, caveat, or question.
Bal et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: